ada standards of care 2025 glp-1 receptor agonists recommendations Beyond Blood Sugar: A Scoping Review in Cardiovascular 2025 ADA Standards of Medical

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

Study results: what did they find

Here, we aimed to provide an overview of retatrutide's safety and effectiveness in treating obesity.

Understand the GLP-1 mechanism behind Ozempic and how it helps manage blood sugar, control appetite, and aid in weight loss using semaglutide.

The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...